A METHOD FOR QUANTIFYING BEVACIZUMAB
Brevet
This item was published in
2017
English Abstract
The present invention relates to the use of an Internal Standard compound in a method for quantifying Bevacizumab in a sample by mass spectrometry, wherein the said Internal Standard compound is described in the specification.
The present invention relates to the use of an Internal Standard compound in a method for quantifying Bevacizumab in a sample by mass spectrometry, wherein the said Internal Standard compound is described in the specification.Read less <
Patent number
PCT/EP2016/072421